Viewing Study NCT00682292

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:49 PM
Ignite Modification Date: 2026-01-09 @ 9:29 PM
Study NCT ID: NCT00682292
Status: COMPLETED
Last Update Posted: 2008-05-22
First Post: 2008-05-20
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Daclizumab Versus Thymoglobulin in Renal Transplant Recipients With High Immunological Risk
Sponsor: University Hospital, Lille
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Transplantation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Renal transplantation View
None Immunisation View
None Acute rejection View
None Induction therapy View
None Thymoglobulin View
None Daclizumab View
None Rejection in sensitized renal transplant recipients View